UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000041158
Receipt number R000047005
Scientific Title Safety-verification test about long-term inhalation of aqueous chloride dioxide aerosol
Date of disclosure of the study information 2021/07/21
Last modified on 2021/06/24 18:52:32

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Safety-verification test about long-term inhalation of aqueous chloride dioxide aerosol

Acronym

Safety-verification test about long-term inhalation of aqueous chloride dioxide aerosol

Scientific Title

Safety-verification test about long-term inhalation of aqueous chloride dioxide aerosol

Scientific Title:Acronym

Safety-verification test about long-term inhalation of aqueous chloride dioxide aerosol

Region

Japan


Condition

Condition

Healthy adults

Classification by specialty

Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To confirm whether a long-term inhalation of aqueous ClO2 aerosol could have adequate safety in vivo.

Basic objectives2

Safety

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Adverse events, and incidence rate of side effects

Key secondary outcomes

1. Body weight
2. Subjective symptoms
3. Hematologic test (WBC)
4. Blood-biochemical test (AST, ALT, gamma-GTP)
5. Immunological test (CRP)


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Prevention

Type of intervention

Other

Interventions/Control_1

Inhalation of aqueous ClO2 aerosol to the volunteer, for 12 weeks (not less than 4 hours a week).

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

(1) Healthy male/female adults.
(2) Expected person working at the CPCC Company office for not less than four hours a week.
(3) Volunteers who gave informed consent to take part in this trial after being provided with an explanation of our experimental protocol detail.

Key exclusion criteria

(1) Volunteers who are now under the other clinical tests with some kind of medicine and/or health food, or took part in those tests within four weeks after the current trial.
(2) Volunteers with current and/or previous medical history of serious diseases in respiratory system.
(3) Volunteers who donated their blood components and/or whole blood (200 mL) within a month to this trial.
(4) Males who donated their whole blood (400 mL) within the last three months to this trial.
(5) Females who donated their whole blood (400 mL) within the last four months to this trial.
(6) Males who will be collected in total of their blood (1200 mL) within the last twelve months, after adding the blood amounts planning to be sampled in this trial.
(7) Females who will be collected in total of their blood (800 mL) within the last twelve months, after adding the blood amounts planning to be sampled in this trial.
(8) Others who have been determined as ineligible for participation in this trial, according to the principal/sub investigator's opinions.

Target sample size

30


Research contact person

Name of lead principal investigator

1st name Suguru
Middle name
Last name Fujiwara

Organization

CPCC Company Limited

Division name

Division of Clinical Research

Zip code

101-0047

Address

4F Sanwa-Uchi-Kanda Building, 3-3-5 Uchi-Kanda, Chiyoda-ku, Tokyo 101-0047, Japan

TEL

03-5297-3112

Email

cpcc-contact@cpcc.co.jp


Public contact

Name of contact person

1st name Mitsuhiro
Middle name
Last name Fujimoto

Organization

CPCC Company Limited

Division name

Planning & Sales Department

Zip code

101-0047

Address

4F Sanwa-Uchi-Kanda Building, 3-3-5 Uchi-Kanda, Chiyoda-ku, Tokyo 101-0047, Japan

TEL

03-5297-3112

Homepage URL


Email

cpcc-contact@cpcc.co.jp


Sponsor or person

Institute

CPCC Company Limited

Institute

Department

Personal name



Funding Source

Organization

BONDS Inc.

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Institutional Review Board of Chiyoda Paramedical Care Clinic

Address

2F Sanwa-Uchi-Kanda Building, 3-3-5 Uchi-Kanda, Chiyoda-ku, Tokyo 101-0047, Japan

Tel

03-5297-5548

Email

IRB@cpcc.co.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2021 Year 07 Month 21 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2020 Year 07 Month 20 Day

Date of IRB

2020 Year 07 Month 17 Day

Anticipated trial start date

2020 Year 07 Month 22 Day

Last follow-up date

2020 Year 11 Month 11 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2020 Year 07 Month 20 Day

Last modified on

2021 Year 06 Month 24 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000047005